China begins trial of COVID-19 vaccine spray
China approved early-stage clinical trials for a nasal spray coronavirus vaccine developed by Xiamen University and Hong Kong University researchers supported by Beijing Wantai Biological Pharmacy Enterprise. The vaccine contains a weakened flu virus with genes from COVID-19's spike protein. The Hill (9/11)
Read full article now.
Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!